-- Bellevue Group acquires Adamant Biomedical from ZKB
-- By Silke Koltrowitz
-- Fri Sep 05, 2014 01:45AM EDT
-- None



ZURICH, Sept 5 (Reuters) - Bellevue Group <BBN.S> said on Friday it was acquiring Adamant Biomedical Investments AG from Zuercher Kantonalbank [ZKB.UL] for an undisclosed price, strengthening its position in healthcare investing.

The deal will add 831 million Swiss francs ($891.06 million) to its assets under management, bringing them to 3.9 billion francs, Bellevue Group said in a statement.